Thaddeus H. Grasela

3.5k total citations
100 papers, 2.6k citations indexed

About

Thaddeus H. Grasela is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Thaddeus H. Grasela has authored 100 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmacology, 16 papers in Pediatrics, Perinatology and Child Health and 16 papers in Epidemiology. Recurrent topics in Thaddeus H. Grasela's work include Antibiotics Pharmacokinetics and Efficacy (21 papers), Statistical Methods in Clinical Trials (15 papers) and Anesthesia and Sedative Agents (14 papers). Thaddeus H. Grasela is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (21 papers), Statistical Methods in Clinical Trials (15 papers) and Anesthesia and Sedative Agents (14 papers). Thaddeus H. Grasela collaborates with scholars based in United States, New Zealand and United Kingdom. Thaddeus H. Grasela's co-authors include Cynthia A. Walawander, Paul G. Ambrose, Lewis B. Sheiner, Evelyn J. Ellis‐Grosse, Alison Meagher, Steven M. Donn, Jerome J. Schentag, Jill Fiedler‐Kelly, Dennis M. Grasela and Julie Passarell and has published in prestigious journals such as PEDIATRICS, Clinical Infectious Diseases and Clinical Cancer Research.

In The Last Decade

Thaddeus H. Grasela

98 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thaddeus H. Grasela United States 31 905 529 461 413 363 100 2.6k
Daniel González United States 28 846 0.9× 377 0.7× 646 1.4× 286 0.7× 360 1.0× 141 2.6k
Alison H. Thomson United Kingdom 27 831 0.9× 390 0.7× 415 0.9× 180 0.4× 334 0.9× 78 2.5k
Roger W. Jelliffe United States 39 2.1k 2.3× 1.2k 2.2× 745 1.6× 495 1.2× 1.2k 3.4× 148 5.0k
Charlotte Kloft Germany 34 1.4k 1.6× 597 1.1× 254 0.6× 363 0.9× 705 1.9× 207 4.1k
Peter G. Welling United States 36 1.3k 1.4× 422 0.8× 681 1.5× 279 0.7× 186 0.5× 123 3.9k
George R. Aronoff United States 32 822 0.9× 293 0.6× 411 0.9× 135 0.3× 305 0.8× 126 3.6k
Ulrika S. H. Simonsson Sweden 29 619 0.7× 544 1.0× 368 0.8× 155 0.4× 1.0k 2.8× 114 2.6k
Gary R. Matzke United States 34 1.5k 1.7× 640 1.2× 634 1.4× 319 0.8× 683 1.9× 147 4.2k
Darwin E. Zaske United States 22 1.2k 1.3× 512 1.0× 374 0.8× 261 0.6× 356 1.0× 59 2.0k
Rashmi H. Barbhaiya United States 31 1.3k 1.5× 498 0.9× 363 0.8× 459 1.1× 484 1.3× 137 3.1k

Countries citing papers authored by Thaddeus H. Grasela

Since Specialization
Citations

This map shows the geographic impact of Thaddeus H. Grasela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thaddeus H. Grasela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thaddeus H. Grasela more than expected).

Fields of papers citing papers by Thaddeus H. Grasela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thaddeus H. Grasela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thaddeus H. Grasela. The network helps show where Thaddeus H. Grasela may publish in the future.

Co-authorship network of co-authors of Thaddeus H. Grasela

This figure shows the co-authorship network connecting the top 25 collaborators of Thaddeus H. Grasela. A scholar is included among the top collaborators of Thaddeus H. Grasela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thaddeus H. Grasela. Thaddeus H. Grasela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cvijić, Sandra, et al.. (2025). Physiologically based pharmacokinetic modeling of hydroxyurea: Implications for dose adjustment in patients with renal insufficiency. Journal of Pharmaceutical Sciences. 114(11). 104004–104004.
2.
Mukonzo, Jackson, et al.. (2023). Expanding regulatory science: Regulatory complementarity and reliance. Clinical and Translational Science. 17(1). e13683–e13683. 1 indexed citations
3.
Fetterly, Gerald J., Thaddeus H. Grasela, Jeffrey W. Sherman, et al.. (2008). Pharmacokinetic/Pharmacodynamic Modeling and Simulation of Neutropenia during Phase I Development of Liposome-Entrapped Paclitaxel. Clinical Cancer Research. 14(18). 5856–5863. 56 indexed citations
4.
Barie, Philip S., Ori D. Rotstein, E. Patchen Dellinger, Thaddeus H. Grasela, & Cynthia A. Walawander. (2004). The Cost-Effectiveness of Cefepime plus Metronidazole versus Imipenem/Cilastatin in the Treatment of Complicated Intra-Abdominal Infection. Surgical Infections. 5(3). 269–280. 7 indexed citations
5.
Johnston, Joseph A., Jill Fiedler‐Kelly, Elbert D. Glover, et al.. (2001). Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation. Nicotine & Tobacco Research. 3(2). 131–140. 66 indexed citations
6.
Grasela, Thaddeus H., et al.. (2001). A population pharmacokinetic‐pharmacodynamic analysis and model validation of azimilide. Clinical Pharmacology & Therapeutics. 70(4). 370–383. 16 indexed citations
7.
Lockwood, G., et al.. (1999). Characterization of the highly variable bioavailability of tiludronate in normal volunteers using population pharmacokinetic methodologies. European Journal of Drug Metabolism and Pharmacokinetics. 24(3). 249–254. 8 indexed citations
8.
Calis, Karim A., et al.. (1997). Symptomatic Cardiotoxicity Associated with 5‐Fluorouracil. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(4). 729–736. 116 indexed citations
9.
Schmith, Virginia D., et al.. (1997). Prospective Use of Population Pharmacokinetics/ Pharmacodynamics in the Development of Cisatracurium. Pharmaceutical Research. 14(1). 91–97. 24 indexed citations
10.
Welage, Lynda S., Cynthia A. Walawander, Linda C. Duffy, et al.. (1995). Sepsis Syndrome and Associated Sequelae in Patients at High Risk for Gram‐Negative Sepsis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(1). 66–77. 5 indexed citations
11.
Grasela, Thaddeus H., et al.. (1994). Use of Antifungal Therapy in Hospitalized Patients II. Results after the Marketing of Fluconazole. Annals of Pharmacotherapy. 28(2). 261–270. 7 indexed citations
12.
Goss, Thomas F., et al.. (1992). Prospective evaluation of risk factors for antibiotic-associated bleeding in critically ill patients.. PubMed. 12(4). 283–91. 6 indexed citations
13.
White, Donald B., et al.. (1992). Evaluation of hypothesis testing for comparing two populations using NONMEM analysis. Journal of Pharmacokinetics and Biopharmaceutics. 20(3). 295–313. 37 indexed citations
14.
Antal, Edward J., Thaddeus H. Grasela, & Randall B. Smith. (1991). The application of population pharmacokinetic analysis to large scale clinical efficacy trials. Journal of Pharmacokinetics and Biopharmaceutics. 19(S3). S37–S46. 5 indexed citations
15.
Grasela, Thaddeus H., et al.. (1990). A Nationwide Survey of Antibiotic Prescribing Patterns and Clinical Outcomes in Patients with Bacterial Pneumonia. DICP. 24(12). 1220–1225. 20 indexed citations
16.
Grasela, Thaddeus H., et al.. (1989). Prospective Surveillance of Antibiotic‐Associated Coagulopathy in 970 Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 9(3). 158–164. 15 indexed citations
17.
Antal, Edward J., Thaddeus H. Grasela, & Randall B. Smith. (1989). An evaluation of population pharmacokinetics in therapeutic trials. Part III. Prospective data collection versus retrospective data assembly. Clinical Pharmacology & Therapeutics. 46(5). 552–559. 30 indexed citations
18.
Schentag, Jerome J., Lynda S. Welage, James S. Williams, et al.. (1988). Kinetics and action of N-methylthiotetrazole in volunteers and patients. The American Journal of Surgery. 155(5). 40–44. 11 indexed citations
19.
Grasela, Thaddeus H., et al.. (1987). A Clinical Pharmacy-Oriented Drug Surveillance Network: II. Results of a Pilot Project. Drug Intelligence & Clinical Pharmacy. 21(11). 909–914. 7 indexed citations
20.
Viscardi, Rose M., et al.. (1985). Efficacy of theophylline for prevention of post-extubation respiratory failure in very low birth weight infants. The Journal of Pediatrics. 107(3). 469–472. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026